Product
Radian®
Radian® is the WASPLab® module dedicated to the full automation and interpretation of Disk Diffusion Antibiotic Susceptibility Testing.

Scientific Study
Evaluation of Standardized Automated Rapid Antimicrobial Susceptibility Testing of Enterobacterales-Containing Blood Cultures: a Proof-of-Principle Study
Stefano Mancini, Elias Bodendoerfer, Natalia Kolensnik-Goldmann, Sebastian Herren, Kim Ro ̈thlin, Patrice Courvalin and Erik C. Bottger
Fair
VIII Congresso Nazionale SIMaST: Farmaco resistenza nelle infezioni sessualmente trasmesse
An Italian event dedicated to AntiMicrobial-Resistant Bacteria in Sexually transmitted infections. The scientific program will cover both the epidemiological aspects and the problems of diagnosis, treatment, and primary and secondary prevention of viral STIs.
News
Meet Radian® BC
Radian® BC is our latest solution to drastically reduce the time to diagnosis in Blood Stream Infection patients. By cutting to 4 hours the incubation time for positive blood culture samples, Radian BC guarantees to specialists unparalleled fast diagnostic assessment, directing each patient towards an early targeted antimicrobial therapy. line laboratory workflow in COVID-19 screening.

Article Focus
Fully Automated EUCAST Rapid Antimicrobial Susceptibility Testing (RAST) from Positive Blood Cultures: Diagnostic Accuracy and Implementation
Even though we’ve already covered this study in our October Microbiology Time, this latest piece of evidence on the importance of Automated RAST in helping patients get prompt treatment indications surely deserves additional attention. Discover the study details and read the full Open access article!

News
Radian® RAST: Pushing Antimicrobial Susceptibility Testing at full speed
After launching Radian’s fully automated disk-diffusion Antibiotic Susceptibility Testing and offering Rapid AST for positive blood cultures, we are now ready to bring RAST advantages to other types of samples.

Video
Radian® BC
Radian BC guarantees to specialists unparalleled fast diagnostic assessment, directing each patient towards an early targeted antimicrobial therapy.
